Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GeneNews Ltd announces conversion of convertible debentures into common shares

Thursday, 19 Dec 2013 10:10am EST 

GeneNews Ltd:Says the conversion of $2,728,942 outstanding convertible debentures of the company plus accrued interest of $2,046,708 into a total of 10,160,957 common shares of the Company. 

Company Quote

0.01 +0.57%
2:35pm EST